Achieve Life Sciences Inc. Common Shares (ACHV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Achieve Life Sciences Inc. Common Shares (ACHV) is Neutral.

The composite score behind that read is +0.03, weighing +0.13 of bullish evidence against -0.29 bearish.

Achieve Life Sciences Inc. Common Shares last closed at $7.41, +3.06% on the session.

Against the IVW growth benchmark the position is +2.26% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

1 graded prediction for ACHV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Achieve Life Sciences Inc. Common Shares in the 1st percentile on return on equity, where 100 is best.

Achieve Life Sciences Inc. Common Shares is classified under Health Care / Biotechnology, with a market capitalisation of $739.87M.

StockMap tracks Achieve Life Sciences Inc. Common Shares as the 149th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Achieve Life Sciences Inc. Common Shares ranks 71st of 381 in the group, against a group median of -0.08.